About the Project
The GW4 BioMed3 Doctoral Landscape Programme is offering up to 18 MRC funded studentships across a range of biomedical disciplines, with a start date of October 2027.
These four-year studentships provide funding for fees and stipend at the rate set by the UKRI, as well as other research training and support costs, and are available to UK and International students.
About the GW4 BioMed3 Doctoral Landscape Programme
The partnership brings together the Universities of Bath, Bristol, Cardiff (lead), and Exeter to train, support and develop graduates with strong research, critical analysis, creative problem solving and translational skills, equipping them for careers in the UK and globally. Our vision aligns research and skills development with UK Government priorities for the life sciences sector, while nurturing contributions to improve health outcomes and the economy worldwide.
Students will have access to the combined research strengths, training expertise, and resources of the four research-intensive universities, with opportunities to participate in interdisciplinary science. GW4 BioMed has previously awarded over 100 studentships across 6 cohorts in its first phase, along with 99 students over 5 cohorts in its second phase. GW4 BioMed3 will be our third, starting in October 27.
This project is in competition for place with the projects across the MRC GW4 BioMed3 Doctoral Landscape Award studentships. There are a total of 18 studentships available across the partnership.
The 134 projects available for application, are aligned to the following themes;
- Cardiometabolic Disease
- Infection, Immunity, and Antimicrobial Resistance
- Neuroscience and Mental Health
- Population Health Sciences
Applications open on Wednesday 9th September and close at 5.00pm on Wednesday 21st October 2026. Please note that we may close the application process before the stated deadline if an unprecedented number of applications are received– check our website for details.
Studentships will be 4 years full time. Part-time study may also be available.
Project Information
As antibiotic resistance threatens modern medicine, phage therapy is emerging as a powerful new weapon against bacterial infections. These naturally occurring viruses selectively destroy harmful bacteria, offering hope where antibiotics fail. Yet a major challenge remains: how do we use phage to treat infections caused by multiple bacterial species at once? Could eliminating one pathogen unintentionally allow another to flourish? This PhD will tackle this critical question, uncovering when such risks arise and developing strategies to optimise phage therapy for co-infections, helping unlock its full potential as a next-generation antimicrobial treatment.
For further information or to apply click here: https://www.exeter.ac.uk/study/funding/award/?id=5928
Funding Notes
These studentships are funded through GW4 BioMed3 MRC Doctoral Landscape Programme and consist of UK tuition fees, as well as a Doctoral Stipend matching UK Research Council National Minimum (£21,805 p.a. for 2026/27, updated each year).
Additional research training and support funding of up to £5,000 per annum is also available.
This is a Preview Listing…
You must sign in to see the full job description, and to apply.
Manage / Upgrade this job to a Full Job Listing.
Find Your Best Opportunity
Tell them AcademicJobs.com sent you!